Yet while SPY's 14% return is certainly impressive��specially for just six months��his pales in comparison to what investors have seen in a few choice sectors. These market segments have risen roughly twice as much as what we have seen in the S&P 500 in the same time period, suggesting that these have been excellent picks for investors during this six month time frame (read 3 Top Ranked Mid Cap ETFs to Buy Now).
Plus, these sectors appear to be well-positioned in the second half of the year, as the trends that propelled the space higher to begin 2013 are still in place. For this reason, investors might want to take a closer look at the top performing ETFs in the best sectors below, as they could provide for some great ideas to close out 2013 as well.
Best Logistics Stocks For 2015: American Public Education Inc.(APEI)
American Public Education, Inc., together with its subsidiary, American Public University System, Inc., provides online postsecondary education focusing on the needs of the military and public service communities. The company operates through two universities, American Military University (AMU) and American Public University (APU) serving approximately 110,000 students in the United States and internationally. The universities share a common faculty and curriculum, which includes 87 degree programs and 69 certificate programs in disciplines related to national security, military studies, intelligence, homeland security, criminal justice, technology, business administration, education, nursing, and liberal arts. The company was founded in 1991 and is headquartered in Charles Town, West Virginia.
Advisors' Opinion:- [By James Brumley]
American Public Education (APEI) has been one of the biggest victims of the DOE’s partial shutdown. The 41,000 individual online classes scheduled to begin a few days ago were reduced by 13,000 when many military and government employees lost their tuition assistance as of October 1st.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on American Public Education (Nasdaq: APEI ) , whose recent revenue and earnings are plotted below. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Non-cyclical consumer goods & services shares climbed around 0.22 percent in trading on Friday. Leading the sector was strength from American Public Education (NASDAQ: APEI) and XO Group (NASDAQ: XOXO). In trading on Friday, telecommunications services shares were relative laggards, down on the day by about 0.41 percent.
Top 10 Mid Cap Companies To Buy Right Now: J.D. HUTT Corp (JABA)
J.D. Hutt Corporation, formerly Gold Standard Mining Corp. incorporated on December 11, 2007, packages water supplies for worldwide distribution to areas affected by emergencies or disasters. As of October 15, 2012, the Company had the equipment and resources to supply and package two gallon boxes of water on a large scale and on short notice to emergencies anywhere in the world. In August 2013, J.D. Hutt Corporation announced the acquisition of Sea Treasure Recovery Corp.
As of December 31, 2011, the Company was in the process of reaching out to federal emergency management agency (FEMA), the Red Cross, and other charities and foundations that provide aid during emergencies. The Company focuses to contract with sources of water to enable the Company to respond to disasters and emergencies.
Advisors' Opinion:- [By Jonathan Yates]
The timing for JD Hutt's (OTCBB: JABA) acquisition of Sea Treasure Recovery Corp. could not have been better as the news channels are filled today with the recovery of $350,000 in sunken treasure off the Florida coast.
Top 10 Mid Cap Companies To Buy Right Now: ABIOMED Inc.(ABMD)
Abiomed, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company?s products are designed to enable the heart to rest, heal, and recover by enhancing blood flow and/or performing the pumping function of the heart. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. Its products are used in the cardiac catheterization lab by interventional cardiologists and/or in the heart surgery suite by heart surgeons. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. Abiomed, Inc. was founded in 1981 and is based in Danvers, Massachusetts.
Advisors' Opinion:- [By John Udovich]
Small cap heart stocks Sunshine Heart Inc (NASDAQ: SSH), Abiomed, Inc (NASDAQ: ABMD) and AtriCure Inc (NASDAQ: ATRC) each find different ways go to the heart of the problem for cardiac�patients and have all been good performers for investors this year. After all and according to statistics collected by the CDC, heart disease is the leading cause of death for both men and women as about 600,000 people die of heart disease in the United States every year���accounting�for 1 in every 4 deaths. Moreover, roughly 715,000 Americans have a heart attack every year and�ff these, 525,000 are a first heart attack and 190,000 happen to people who have already had one. In other words, there is a big market for the following small cap heart stocks to address:
Top 10 Mid Cap Companies To Buy Right Now: Medifirst Solutions Inc (MFST)
Medifirst Solutions, Inc. (MSI), incorporated in November 2010, is a development-stage company. The Company is engaged in business planning activities, including researching the industry, identifying target markets for its products, developing its Medifirst Solutions, Inc. models and financial forecasts. The Company has diverse product line, including both consumer products and digital media. The Company intends to launch Florida Health Community as an on-line healthcare directory and social media site geared towards both professionals and consumers. MSI also intends to produce a tabloid size newsletter with healthcare industry related news and events. Its products include Miracle-cig and Florida Health Community Website and newsletter. In February 2014, the Company announced that it has acquired Consumer Resources Consultants Inc., a provider of online remote technical support to PC users.
The Florida Health Community Website is designed to be a medical directory with a social media component for users. The Miracle-cig is a name for its brand of disposable electronic cigarette. It is sold online at www.miraclecig.com. It intends to offer the Miracle-cig through retail outlets and convenience stores throughout the United States. It intends to add an electronic cigarette that is packaged and marketed to consumers 21 to 25 years old. The Miracle-cig will be sold at a suggested retail price of $9.95 per unit. It purchases the Miracle-cig directly from the manufacturer in China. Florida Health Community.com (FHC) is a Website currently under construction.
The Company competes with Green Smoke, NJOY. Eco and Blu.
Advisors' Opinion:- [By Peter Graham]
The marijuana field keeps sprouting small cap marijuana stocks like Primco Management Inc (OTCBB: PMCM), Medifirst Solutions Inc (OTCMKTS: MFST) and Modern Mobility Aids, Inc (OTCMKTS: MDRM) which are all trying to seek a high by playing up their connections (no matter how tenuous�� to what many consider to be the next high flying sector. But are these small cap marijuana stocks just blowing smoke at investors? Here is a quick reality check:
Top 10 Mid Cap Companies To Buy Right Now: Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV). These inhibitors include members of the direct acting antiviral (DAA) inhibitor classes-protease (partnered with AbbVie, the former research-based pharmaceutical business of Abbott Laboratories), NS5A (partnered with Novartis) and nucleotide polymerase, as well as a host targeted antiviral (HTA) inhibitor class targeted against cyclophilin. ABT-450, discovered through its collaboration with AbbVie, is a protease inhibitor that has demonstrated in vitro potency against known resistant HCV mutants.
In Phase I studies, ABT-450 co-administered with ritonavir, a commonly used boosting agent to increase the blood concentrations of many protease inhibitors, was shown to be safe and well tolerated. Co-administration of ABT-450 with ritonavir, which it refers to together as ABT-450/r, has enabled once-daily dosing of ABT-450. Phase II studies have demonstrated the efficacy of ABT-450/r in patients with chronic HCV, and other interferon-free Phase II studies of ABT-450-containing regimens continue. AbbVie is developing a next-generation protease inhibitor discovered within the Enanta-AbbVie collaboration. EDP-239 is the NS5A inhibitor discovered by the Company. The Company also has a program to develop nucleotide inhibitors to HCV NS5B polymerase, which is another DAA mechanism considered to have a barrier to resistance. The Company�� Bicyclolide antibiotic product candidate is EDP-788, which it is developing for use as an intravenous drug in the hospital setting and for oral dosing in the home setting. EDP-788 is a prodrug, which means that it is inactive until it is converted in the body into an active compound. EDP-788 is! a water-soluble molecule which, when administered in preclinical models, is cleanly and rapidly converted into the active compound.
Advisors' Opinion:- [By Sean Williams]
The next big thing in treating hepatitis-C
The other currently experimental therapy very likely to make it onto the FDA's desk before the midpoint of 2014 is AbbVie's (NYSE: ABBV ) direct-acting antiviral combo drug. In similar fashion to Sovaldi, this DAA-combo therapy, which includes ABT-450 from Enanta Pharmaceuticals (NASDAQ: ENTA ) , is running six confirmatory late-stage trials on various genotypes. There are, however, two primary differences between AbbVie's DAA-combo therapy and Sovaldi. - [By George Budwell]
Normally, such strong efficacy results would be hailed as a major achievement. However, these results are actually less impressive than those by competing drug's developed by AbbVie (NYSE: ABBV ) , Enanta Pharmaceuticals (NASDAQ: ENTA ) and Gilead. Bristol-Myers' therapy also has a treatment duration double that of Gilead's drug Sovaldi for genotype 1 patients. So, while these results are impressive in their own right, the therapy's commercial prospects may be limited due to the presence of superior competitors in the market.�
- [By James Fink]
And lastly I'll go into healthcare, which is kind of a growth cyclical type name. It's partially defensive, partially growth. I think the more growth-oriented section of healthcare would be biotech, and right now, a very promising biotech stock is Enanta Pharmaceuticals. That's a NASDAQ stock; ticker symbol (ENTA).
Top 10 Mid Cap Companies To Buy Right Now: iShares 1-3 Year Credit Bond ETF (CSJ)
iShares Lehman 1-3 Year Credit Bond Fund (the Fund) seeks investment results that correspond to the price and yield performance of the investment-grade credit sector of the United States bond market as defined by the Lehman Brothers 1-3 Year U.S. Credit Index (the Index). The Index measures the performance of investment-grade United States credit securities, corporate debt and sovereign, local authority and non-United States agency bonds that are United States dollar denominated.
The Fund invests in a representative sample of the securities in the Index, which has a similar investment profile as the Index. The Index includes investment grade United States credit securities that have a remaining maturity of greater than or equal to one year and less than three years, and have more than $250 million or more of outstanding face value. Barclays Global Fund Advisors serves as an advisor to the Fund.
Advisors' Opinion:- [By GURUFOCUS]
In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
- Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
- Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
- Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%
Top 10 Mid Cap Companies To Buy Right Now: Blackrock Enhanced Equity Dividend Trust (BDJ)
BlackRock Enhanced Dividend Achievers Trust (the Trust) is a diversified closed-end management investment company. The Trust�� primary investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve these objectives by investing in common stocks that pay above average dividends and have the potential for capital appreciation and by utilizing an option writing strategy to enhance distributions paid to the Trust�� shareholders.
Under normal market conditions, the Trust will invest at least 80% of its total assets in common stocks that are included in the universe of common stocks of issuers, which Mergent has determined are Dividend Achievers and options with exposure to such stocks. From time to time, the Trust may invest up to 20% of its total assets in investments without exposure to the Dividend Achievers universe. As part of its investment strategy, the Trust intends to employ a strategy of writing (selling) covered call and put options on individual common stocks, indices of securities, sectors of securities and baskets of securities.
Advisors' Opinion:- [By Robert Hsu]
Name Type of Security� Recommendation� Kinder Morgan Energy Partners L.P. (NYSE: KMP) � MLP August 15, 2013� TeeKay LNG Partners L.P.� (NYSE: TGP) � MLP September 16, 2013� PowerShares S&P 500 BuyWrite Portfol ETF� (NYSE Arca: PBP)� Buy-Write ETF September 30, 2013� Madison Covered Call Equity Strtgy Fd (NYSE: MCN)� Buy-Write ETF September 30, 2013� Nuveen Equity Premium Opportunity Fund (NYSE: JSN)� Buy-Write ETF September 30, 2013� BlackRockEnhanced Dividend Achievers Tr (NYSE: BDJ)� Buy-Write ETF September 30, 2013� Vornado Realty Trust � (NYSE: VNO)� Real Estate
Investment
Trust September 26, 2013�Robert Hsu is the editor of Permanent Wealth Investor and a former hedge fund portfolio manager at Wall Street powerhouse Goldman Sachs. He retired from Goldman at age 31. He since has come out of retirement to establish and preside over his money management firm, Absolute Return Capital Advisors. His retirement experience has given him his current mission: helping investors like you achieve their goal of comfortable retirement through profitable income strategies.
- [By Robert Hsu]
Here are four to consider:
PowerShares S&P 500 BuyWrite ETF (PBP), yielding 4.09%
Madison/Claymore Covered Call & Equity Strategy (MCN), yielding 8.94%
Nuveen Equity Premium Opportunity Fund (JSN), yielding 9.19%
BlackRock Enhanced Dividend Achievers (BDJ), yielding 7.39%
The yield on these funds is very attractive. Even more attractive is the fact that many buy-write funds actually are selling at a discount to their net asset value.
No comments:
Post a Comment